Article
Identification and validation of an inflammatory response-related signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer
2024-04-11
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Immunotherapy has revolutionized non-small cell lung cancer (NSCLC ) therapy, only a small proportion of patients demonstrate durable antitumor response due to the heterogeneity. Emerging evidence has linked inflammatory response to progression, anticancer therapeutic resistance, and poor prognosis of NSCLC. This study aimed to classify distinct inflammatory res...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 55b453a9-26ba-578f-b4b1-007e38de0104
- DOI
- 10.21203/rs.3.rs-4129788/v1
